10.95
-0.05
(-0.45%)
As of 9:13:56 AM GMT+1. Market Open.
Breakdown
TTM
2/29/2024
2/28/2023
2/28/2022
2/28/2021
Total Revenue
3,546,876.00
3,786,876.00
3,637,442.00
2,901,544.00
2,546,984.00
Cost of Revenue
--
2,721,693.00
2,634,313.00
2,068,199.00
1,770,941.00
Gross Profit
--
1,065,183.00
1,003,129.00
833,345.00
776,043.00
Operating Expense
--
899,629.00
841,654.00
756,359.00
718,345.00
Operating Income
67,254.00
165,554.00
161,475.00
76,986.00
57,698.00
Net Non Operating Interest Income Expense
--
-38,709.00
-18,334.00
-12,021.00
-12,403.00
Pretax Income
12,802.00
97,702.00
61,718.00
8,633.00
60,195.00
Tax Provision
7,049.00
28,349.00
37,035.00
20,866.00
5,210.00
Net Income Common Stockholders
3,825.00
64,925.00
15,816.00
-12,612.00
59,787.00
Diluted NI Available to Com Stockholders
3,825.00
64,925.00
15,816.00
-12,612.00
59,787.00
Basic EPS
0.06
1.04
0.25
-0.20
0.96
Diluted EPS
0.06
1.04
0.25
-0.20
0.96
Basic Average Shares
63,113.98
62,488.98
62,488.98
62,488.98
62,488.98
Diluted Average Shares
62,251.19
62,488.98
62,488.98
62,488.98
62,488.98
Total Operating Income as Reported
52,711.00
151,011.00
88,260.00
24,732.00
78,691.00
Rent Expense Supplemental
--
7,572.00
6,559.00
5,777.00
6,017.00
Total Expenses
--
3,621,322.00
3,475,967.00
2,824,558.00
2,489,286.00
Net Income from Continuing & Discontinued Operation
3,825.00
64,925.00
15,816.00
-12,612.00
59,787.00
Normalized Income
13,383.78
80,909.94
101,411.00
41,279.25
53,886.28
Interest Income
--
2,986.00
1,199.00
742.00
802.00
Interest Expense
--
37,240.00
13,960.00
8,124.00
8,779.00
Net Interest Income
--
-38,709.00
-18,334.00
-12,021.00
-12,403.00
EBIT
36,642.00
134,942.00
75,678.00
16,757.00
68,974.00
EBITDA
36,642.00
249,191.00
285,692.00
194,129.00
189,427.00
Reconciled Cost of Revenue
--
2,721,693.00
2,634,313.00
2,068,199.00
1,770,941.00
Reconciled Depreciation
--
114,249.00
210,014.00
177,372.00
120,453.00
Net Income from Continuing Operation Net Minority Interest
3,825.00
64,925.00
15,816.00
-12,612.00
59,787.00
Total Unusual Items Excluding Goodwill
-12,414.00
-22,514.00
-112,625.00
-71,855.00
6,463.00
Total Unusual Items
-12,414.00
-22,514.00
-112,625.00
-71,855.00
6,463.00
Normalized EBITDA
49,056.00
271,705.00
398,317.00
265,984.00
182,964.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-2,855.22
-6,529.06
-27,030.00
-17,963.75
562.28
2/28/2021 - 10/24/2002
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1375.T Yukiguni Maitake Co., Ltd.
1,163.00
-0.09%
93X.F Promino Nutritional Sciences R
0.0270
-23.94%
SNX.ST Premium Snacks Nordic AB (publ)
20.60
+0.98%
VEZ.F Veganz Group AG
6.58
-4.08%
NXFR.TA NextFerm Technologies Ltd
178.50
+1.88%
SCST.ST Scandi Standard AB (publ)
83.30
-0.24%
REGENTRP.BO Regent Enterprises Limited
8.58
-2.50%
BFNH BioForce Nanosciences Holdings, Inc.
0.6600
0.00%
009780.KQ MSC Co., Ltd.
5,760.00
-0.86%
SIS.L Science in Sport plc
26.50
+6.00%